You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

342 Results
Cancer screening can find abnormal cell changes before they become cancer or cancer at an early stage, when treatment has a better chance of working...
The following information answers many of the questions primary care physicians commonly ask about the Screening Activity Report and the included...
A variety of screening tools and resources are available to support the screening activities of primary care providers, nurses and specialists.
Drug
Other Name(s): Sylvant®
Mar 2025
Regimen
Cancer Type:
Hematologic, 
Rare Diseases
Intent: Palliative
Funding:
New Drug Funding Program
    Siltuximab - Multicentric Castleman’s Disease (MCD)
Mar 2025
Les programmes cliniques d’Action Cancer Ontario sont mis en œuvre en collaboration avec les cliniciens des Programmes régionaux de cancérologie en...
Drug
Other Name(s): Iressa®
Mar 2025
Le dépistage du cancer du poumon dans le cadre du Programme ontarien de dépistage du cancer du poumon est offert aux personnes admissibles dans un...

Pages